These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3569760)

  • 41. Effects of tolvaptan on systemic and renal hemodynamic function in dogs with congestive heart failure.
    Onogawa T; Sakamoto Y; Nakamura S; Nakayama S; Fujiki H; Yamamura Y
    Cardiovasc Drugs Ther; 2011 Dec; 25 Suppl 1():S67-76. PubMed ID: 22120095
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect of hyperglycemia on the clearances of inulin and para-aminohippuric acid.
    GRIMELLI LJ; CHERTACK MM
    J Lab Clin Med; 1948 Dec; 33(12):1617. PubMed ID: 18100178
    [No Abstract]   [Full Text] [Related]  

  • 43. Effects of IGF-I on renal function in patients with chronic renal failure.
    O'Shea MH; Miller SB; Hammerman MR
    Am J Physiol; 1993 May; 264(5 Pt 2):F917-22. PubMed ID: 8498545
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Renal response to furosemide in conscious rats: effects of acute instrumentation and peripheral sympathectomy.
    Petersen JS; Shalmi M; Lam HR; Christensen S
    J Pharmacol Exp Ther; 1991 Jul; 258(1):1-7. PubMed ID: 2072287
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Impact of the induced organic anion transporter 1 (Oat1) renal expression by furosemide on the pharmacokinetics of organic anions.
    Severin MJ; Hazelhoff MH; Bulacio RP; Mamprin ME; Brandoni A; Torres AM
    Nephrology (Carlton); 2017 Aug; 22(8):642-648. PubMed ID: 27282888
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term administration of isosorbide-5-mononitrate does not impair renal function in cirrhotic patients.
    Salerno F; Borroni G; Lorenzano E; Solenghi D; Cazzaniga M; Bissoli F; Ceriani R; deFranchis R
    Hepatology; 1996 May; 23(5):1135-40. PubMed ID: 8621145
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The influence of indomethacin on the pharmacokinetics, diuretic response and hemodynamics of furosemide in the dog.
    Data JL; Rane A; Gerkens J; Wilkinson GR; Nies AS; Branch RA
    J Pharmacol Exp Ther; 1978 Aug; 206(2):431-8. PubMed ID: 682123
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid diuresis in patients with ascites from chronic liver disease: the importance of peripheral edema.
    Pockros PJ; Reynolds TB
    Gastroenterology; 1986 Jun; 90(6):1827-33. PubMed ID: 3699402
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Renal effects of treatment with diuretics, octreotide or both, in non-azotemic cirrhotic patients with ascites.
    Kalambokis G; Economou M; Fotopoulos A; Bokharhii JA; Katsaraki A; Tsianos EV
    Nephrol Dial Transplant; 2005 Aug; 20(8):1623-9. PubMed ID: 15886218
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transjugular intrahepatic portosystemic stent shunt: effects on hemodynamics and sodium homeostasis in cirrhosis and refractory ascites.
    Wong F; Sniderman K; Liu P; Allidina Y; Sherman M; Blendis L
    Ann Intern Med; 1995 Jun; 122(11):816-22. PubMed ID: 7741365
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Selective dopamine DA1 stimulation with fenoldopam in cirrhotic patients with ascites: a systemic, splanchnic and renal hemodynamic study.
    Hadengue A; Moreau R; Bacq Y; Gaudin C; Braillon A; Lebrec D
    Hepatology; 1991 Jan; 13(1):111-6. PubMed ID: 1671029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cyclooxygenase-1 derived prostaglandins are involved in the maintenance of renal function in rats with cirrhosis and ascites.
    López-Parra M; Clària J; Planagumà A; Titos E; Masferrer JL; Woerner BM; Koki AT; Jiménez W; Altuna R; Arroyo V; Rivera F; Rodés J
    Br J Pharmacol; 2002 Feb; 135(4):891-900. PubMed ID: 11861316
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The long-term effect of propranolol therapy on renal function.
    Bauer JH; Brooks CS
    Am J Med; 1979 Mar; 66(3):405-10. PubMed ID: 433946
    [No Abstract]   [Full Text] [Related]  

  • 54. Influence of intravenous acetylsalicylic acid and sodium salicylate on human renal function and lithium clearance.
    Reimann IW; Golbs E; Fischer C; Frölich JC
    Eur J Clin Pharmacol; 1985; 29(4):435-41. PubMed ID: 3912188
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of intrarenal furosemide on renal function and intratenal hemodynamics in acute renal failure.
    Epstein M; Schneider NS; Befeler B
    Am J Med; 1975 Apr; 58(4):510-6. PubMed ID: 1124788
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of volume expansion and furosemide diuresis on the renal clearance of digoxin.
    Gibson TP; Quintanilla AP
    J Pharmacol Exp Ther; 1981 Oct; 219(1):54-9. PubMed ID: 6793714
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of the effect of furosemide on ultrafilterable platinum kinetics in patients treated with cis-diamminedichloroplatinum.
    Dumas M; de Gislain C; d'Athis P; Chadoint-Noudeau V; Escousse A; Guerrin J; Autissier N
    Cancer Chemother Pharmacol; 1989; 23(1):37-40. PubMed ID: 2909288
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of medullary plasma flow in the attenuated furosemide response in indomethacin-treated rats.
    Kirchner KA
    J Pharmacol Exp Ther; 1989 Jun; 249(3):757-61. PubMed ID: 2732945
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effects of sulfinpyrazone on renal function and prostaglandin formation in man.
    Rosenkranz B; Fejes-Tóth G; Diener U; Frölich JC
    Nephron; 1985; 39(3):237-43. PubMed ID: 3883211
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Renal actions of azosemide. 1. Clearance investigations in dogs.
    Greven J; Heidenreich O
    Arzneimittelforschung; 1981; 31(2):346-50. PubMed ID: 7194651
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.